Daria V. Mukhametdinova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Daria V. Mukhametdinova has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Михаил Михайлович Галагудза
«V. A. Almazov National Medical Research Center» of the Ministry of Health of the Russian Federation
7 shared publications - Irina A. Zelinskaya
Almazov National Medical Research Centre
6 shared publications - Irina N. Zhilinskaya
Smorodintsev Research Institute of Influenza; North-Western State Medical University named after I. I. Mechnikov
6 shared publications - Vladimir A. Marchenko
North-Western State Medical University Named After I.I. Mechnikov
6 shared publications - Yana G. Toropova
Almazov National Medical Research Centre
5 shared publications - Dmitriy A. Lioznov
Smorodintsev Research Institute of Influenza, 197022 Saint Petersburg, Russia
4 shared publications
Latest Publications
- 25 September 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (3) , 121-136
A study of urinary colloidal and protein composition during the induction of dose-dependent oxalate urolithiasis in rats
INTRODUCTION . Oxalate urolithiasis is a common disease, but the mechanisms underlying the transition from crystalluria to kidney damage remain poorly understood. Of particular interest is the role of uromodulin (UMOD) in crystal formation under varying degrees of hyperoxaluria. AIM. To study the dynamics of the colloidal and protein composition of urine in a rat model of acute oxalate urolithiasis. MATERIALS AND METHODS. The study was conducted using male Wistar rats. Acute oxalate nephropathy was induced by intraperitoneal administration of sodium oxalate (NaOx): 2,5 mg/100 g (NaOx L group) and 5 mg/100 g (NaOx H group). The control group received 0,9 % NaCl. Measurements performed in dynamics (2-4 hours, 4-8 hours, 24 hours). The colloidal fraction of urine was assessed using nanoparticle tracking analysis (NTA). The concentration of immunoreactive UMOD was measured by ELISA, and total UMOD concentration was determined by ultrafiltration combined with the Bradford method. The glomerular filtration rate (GFR) was measured by FITC-inulin clearance. Histological examination of the kidneys was also performed. RESULTS . In the experimental groups, after 2-4 hours, a moderate increase was observed in the concentration of colloidal particles (230-240 nm) and a significant increase in the total UMOD relative to the control (p 0,05). In the NaOx H group, depletion of the UMOD pool (13,9 μg/mL, p = 0,051) was detected, crystal aggregates (20-45 μm) obstructed the lumen of Henle loop in more than 75 % of tubules, dilation of Bowman’s capsules and a critical decrease in GFR by 57,8 % (p CONCLUSIONS . The outcome of acute oxalate nephropathy is determined by the balance between the degree of hyperoxaluria and the UMOD pool. With moderate hyperoxaluria, the local UMOD pool is sufficient to encapsulate crystals and ensure their safe elimination. Under high oxalate load, the UMOD pool is depleted, crystallization in the unprotected UMOD thin segment of Henle loop leads to obstruction. The observed dose dependence explains the differences in the severity of kidney damage with varying degrees of hyperoxaluria.
- 25 September 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (3) , 121-136
A study of urinary colloidal and protein composition during the induction of dose-dependent oxalate urolithiasis in rats
INTRODUCTION . Oxalate urolithiasis is a common disease, but the mechanisms underlying the transition from crystalluria to kidney damage remain poorly understood. Of particular interest is the role of uromodulin (UMOD) in crystal formation under varying degrees of hyperoxaluria. AIM. To study the dynamics of the colloidal and protein composition of urine in a rat model of acute oxalate urolithiasis. MATERIALS AND METHODS. The study was conducted using male Wistar rats. Acute oxalate nephropathy was induced by intraperitoneal administration of sodium oxalate (NaOx): 2,5 mg/100 g (NaOx L group) and 5 mg/100 g (NaOx H group). The control group received 0,9 % NaCl. Measurements performed in dynamics (2-4 hours, 4-8 hours, 24 hours). The colloidal fraction of urine was assessed using nanoparticle tracking analysis (NTA). The concentration of immunoreactive UMOD was measured by ELISA, and total UMOD concentration was determined by ultrafiltration combined with the Bradford method. The glomerular filtration rate (GFR) was measured by FITC-inulin clearance. Histological examination of the kidneys was also performed. RESULTS . In the experimental groups, after 2-4 hours, a moderate increase was observed in the concentration of colloidal particles (230-240 nm) and a significant increase in the total UMOD relative to the control (p 0,05). In the NaOx H group, depletion of the UMOD pool (13,9 μg/mL, p = 0,051) was detected, crystal aggregates (20-45 μm) obstructed the lumen of Henle loop in more than 75 % of tubules, dilation of Bowman’s capsules and a critical decrease in GFR by 57,8 % (p CONCLUSIONS . The outcome of acute oxalate nephropathy is determined by the balance between the degree of hyperoxaluria and the UMOD pool. With moderate hyperoxaluria, the local UMOD pool is sufficient to encapsulate crystals and ensure their safe elimination. Under high oxalate load, the UMOD pool is depleted, crystallization in the unprotected UMOD thin segment of Henle loop leads to obstruction. The observed dose dependence explains the differences in the severity of kidney damage with varying degrees of hyperoxaluria.
- 26 July 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (2) , 96-110
Uromodulin as a kidney protective factor in acute oxalate urolithiasis: a dose-dependent mouse model
INTRODUCTION . Urolithiasis is a common urological pathology with a high recurrence rate. Experimental models on rodents are the main tool for studying the pathogenesis of stone formation and the search for therapeutic targets. THE AIM : To develop models of acute oxalate urolithiasis in ICR mice and evaluate the role of uromodulin (UMO) in protecting the kidneys from crystal-induced damage. MATERIALS AND METHODS. The study was performed on 18 male ICR mice (CD 1). Mice were intraperitoneally injected with sodium oxalate in two doses: 2.5 mg/100 g body weight (NaOx L) and 5 mg/100 g body weight (NaOx H). The biochemical parameters of blood, glomerular filtration rate by FITC inulin clearance, colloidal composition of urine, urinary excretion of UMO and ions, morphology of sediment and internal organs were evaluated in the experiment. RESULTS . A high dose of the pathology inducer caused severe acute nephropathy with pronounced azotemia, decreased GFR, accumulation of large CaOx containing nanoparticles, and deep tubulointerstitial damage. A dose of 2.5 mg/100 g of body weight formed a milder, generally compensated lesion with a transient peak of crystalluria. In this group, the dynamics of urinary UMO excretion and colloidal profile most convincingly demonstrated its nephroprotective and anti-crystallogenic role. CONCLUSIONS. The developed two-dose model of acute Ox urolithiasis in mice allows differentiated study of severe crystal-induced kidney damage (5 mg/100 g) and mechanisms of effective crystal clearance with the participation of UMO (2.5 mg/100 g), which creates the basis for molecular genetic studies on transgenic and knockout lines of mice.
- 26 July 2026
- Published by Non-profit organization Nephrology in Nephrology (Saint-Petersburg)
- Vol. 30 (2) , 96-110
Uromodulin as a kidney protective factor in acute oxalate urolithiasis: a dose-dependent mouse model
INTRODUCTION . Urolithiasis is a common urological pathology with a high recurrence rate. Experimental models on rodents are the main tool for studying the pathogenesis of stone formation and the search for therapeutic targets. THE AIM : To develop models of acute oxalate urolithiasis in ICR mice and evaluate the role of uromodulin (UMO) in protecting the kidneys from crystal-induced damage. MATERIALS AND METHODS. The study was performed on 18 male ICR mice (CD 1). Mice were intraperitoneally injected with sodium oxalate in two doses: 2.5 mg/100 g body weight (NaOx L) and 5 mg/100 g body weight (NaOx H). The biochemical parameters of blood, glomerular filtration rate by FITC inulin clearance, colloidal composition of urine, urinary excretion of UMO and ions, morphology of sediment and internal organs were evaluated in the experiment. RESULTS . A high dose of the pathology inducer caused severe acute nephropathy with pronounced azotemia, decreased GFR, accumulation of large CaOx containing nanoparticles, and deep tubulointerstitial damage. A dose of 2.5 mg/100 g of body weight formed a milder, generally compensated lesion with a transient peak of crystalluria. In this group, the dynamics of urinary UMO excretion and colloidal profile most convincingly demonstrated its nephroprotective and anti-crystallogenic role. CONCLUSIONS. The developed two-dose model of acute Ox urolithiasis in mice allows differentiated study of severe crystal-induced kidney damage (5 mg/100 g) and mechanisms of effective crystal clearance with the participation of UMO (2.5 mg/100 g), which creates the basis for molecular genetic studies on transgenic and knockout lines of mice.
- Open Access
- 1 June 2026
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 16 (2) , 255-265
Impaired vascular endothelium functional properties during the acute phase of influenza A(H3N2) virus-induced infection
Seasonal influenza A viruses including A(H1N1)pdm09 and A(H3N2) subtypes infect over 5–15% of the global population annually. According to epidemiological data, influenza A(H3N2) viruses are associated with more severe disease progression and the development of hemorrhagic syndrome as well as different thrombotic complications associated with activated vascular endothelial cells. The aim of the study was to investigate the effect of influenza A(H3N2) virus on the morphofunctional properties of blood vessel endothelium during the acute phase of infection. Materials and methods. Wistar rats were intranasally infected with influenza A virus A/Port Chalmers/1/1973 (H3N2) in a volume of 0.1 ml and subsequently euthanized at 1- and 4-days post infection (d.p.i.) (n = 5). Animals in control group were intranasally administered DMEM medium (0.1 ml). After necropsy, lung and mesentery tissues were collected to assess viral infectious activity titer. Additionally, severity of histopathological alterations in lung blood vessel endothelium and mesentery was assessed, the expression level of endothelial nitric oxide synthase (eNOS) in pulmonary and mesentery vascular endothelium was measured by immunohistochemical analysis, and the parameters of vasomotor activity in mesenteric arteries using wire myography was assessed. Results. Influenza A(H3N2) virus induced morphological changes in lung blood vessels on days 1 and 4, decreased eNOS expression levels in lung vessel endothelium at 1 d.p.i., and in mesenteric blood vessel endothelium at 1 and 4 d.p.i. Furthermore, the response of mesenteric blood vessels to median phenylephrine concentrations on day 4 vs day 1 d.p.i. was 87.13% higher (p 0.05), while the vascular response to premaximal acetylcholine concentrations on day 4 was 26.15% lower (p 0.05) compared to control. Conclusion. Influenza A virus subtype H3N2 impairs the morphofunctional properties of the blood vessel endothelium in rat lungs and the functional properties of the vascular endothelium in the mesentery during the acute phase of infection, suggesting activation of endothelial cells at both local and systemic levels.
- 1 June 2026
- Published by SPb RAACI in Russian Journal of Infection and Immunity
- Vol. 16 (2) , 255-265
Open AccessImpaired vascular endothelium functional properties during the acute phase of influenza A(H3N2) virus-induced infection
Seasonal influenza A viruses including A(H1N1)pdm09 and A(H3N2) subtypes infect over 5–15% of the global population annually. According to epidemiological data, influenza A(H3N2) viruses are associated with more severe disease progression and the development of hemorrhagic syndrome as well as different thrombotic complications associated with activated vascular endothelial cells. The aim of the study was to investigate the effect of influenza A(H3N2) virus on the morphofunctional properties of blood vessel endothelium during the acute phase of infection. Materials and methods. Wistar rats were intranasally infected with influenza A virus A/Port Chalmers/1/1973 (H3N2) in a volume of 0.1 ml and subsequently euthanized at 1- and 4-days post infection (d.p.i.) (n = 5). Animals in control group were intranasally administered DMEM medium (0.1 ml). After necropsy, lung and mesentery tissues were collected to assess viral infectious activity titer. Additionally, severity of histopathological alterations in lung blood vessel endothelium and mesentery was assessed, the expression level of endothelial nitric oxide synthase (eNOS) in pulmonary and mesentery vascular endothelium was measured by immunohistochemical analysis, and the parameters of vasomotor activity in mesenteric arteries using wire myography was assessed. Results. Influenza A(H3N2) virus induced morphological changes in lung blood vessels on days 1 and 4, decreased eNOS expression levels in lung vessel endothelium at 1 d.p.i., and in mesenteric blood vessel endothelium at 1 and 4 d.p.i. Furthermore, the response of mesenteric blood vessels to median phenylephrine concentrations on day 4 vs day 1 d.p.i. was 87.13% higher (p 0.05), while the vascular response to premaximal acetylcholine concentrations on day 4 was 26.15% lower (p 0.05) compared to control. Conclusion. Influenza A virus subtype H3N2 impairs the morphofunctional properties of the blood vessel endothelium in rat lungs and the functional properties of the vascular endothelium in the mesentery during the acute phase of infection, suggesting activation of endothelial cells at both local and systemic levels.
- Open Access
- 16 September 2025
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 70 (4) , 349-362
Endothelial protective properties of sacubitril-valsartan and drotaverine in influenza A(H1N1)pdm09 virus infection (Orthomyxoviridae: Alphainfluenzavirus: influenza A virus)
Introduction. Severe influenza is characterized by damage and morphofunctional changes of the endothelium of blood vessels, which contributes to the development of hemorrhagic syndrome and can cause endothelial dysfunction. To optimize the pathogenetic therapy of influenza infection, a screening of medications with endothelial protective properties was carried out. Aim. The aim of the study was to evaluate the endothelial protective properties of sacubitril/valsartan and drotaverine in influenza A(H1N1)pdm09 virus infection. Materials and methods. The study was conducted on Wistar rats, which received sacubitril/valsartan and drotaverine (in treatment and prophylactic regimen) followed by intransal infection with influenza A/Saint-Petersburg/48/16 (H1N1)pdm09 virus. Rats without drug administration were included in the control group; rats received no medications followed by influenza virus infection – in challenge control group. The virus infectious activity was determined in pulmonary and mesenteric tissues. Vascular endothelium damage in lungs was assessed by three parameters (desquamation, morphological and dystrophic changes). Endothelial nitric oxide synthase (eNOS) expression level in endothelium of mesenteric blood vessels was determined as well as mesenteric arteries vasomotor activity. Results. Drotaverine reduces the severity of histopathological changes in the pulmonary vascular endothelium; increases the maximal response of mesenteric blood vessels to acetylcholine compared to the infection control group; normalizes eNOS expression levels. Sacubitril/valsartan reduces the severity of desquamation in the pulmonary vascular endothelium; normalizes the response of mesenteric blood vessels to acetylcholine, while eNOS expression is decreased. Conclusions. Drotaverine possesses more significant endothelial protective properties than sacubitril/valsartan when used in a treatment and prophylactic regimen in rats infected with influenza A(H1N1)pdm09 virus.
- 16 September 2025
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 70 (4) , 349-362
Open AccessEndothelial protective properties of sacubitril-valsartan and drotaverine in influenza A(H1N1)pdm09 virus infection (Orthomyxoviridae: Alphainfluenzavirus: influenza A virus)
Introduction. Severe influenza is characterized by damage and morphofunctional changes of the endothelium of blood vessels, which contributes to the development of hemorrhagic syndrome and can cause endothelial dysfunction. To optimize the pathogenetic therapy of influenza infection, a screening of medications with endothelial protective properties was carried out. Aim. The aim of the study was to evaluate the endothelial protective properties of sacubitril/valsartan and drotaverine in influenza A(H1N1)pdm09 virus infection. Materials and methods. The study was conducted on Wistar rats, which received sacubitril/valsartan and drotaverine (in treatment and prophylactic regimen) followed by intransal infection with influenza A/Saint-Petersburg/48/16 (H1N1)pdm09 virus. Rats without drug administration were included in the control group; rats received no medications followed by influenza virus infection – in challenge control group. The virus infectious activity was determined in pulmonary and mesenteric tissues. Vascular endothelium damage in lungs was assessed by three parameters (desquamation, morphological and dystrophic changes). Endothelial nitric oxide synthase (eNOS) expression level in endothelium of mesenteric blood vessels was determined as well as mesenteric arteries vasomotor activity. Results. Drotaverine reduces the severity of histopathological changes in the pulmonary vascular endothelium; increases the maximal response of mesenteric blood vessels to acetylcholine compared to the infection control group; normalizes eNOS expression levels. Sacubitril/valsartan reduces the severity of desquamation in the pulmonary vascular endothelium; normalizes the response of mesenteric blood vessels to acetylcholine, while eNOS expression is decreased. Conclusions. Drotaverine possesses more significant endothelial protective properties than sacubitril/valsartan when used in a treatment and prophylactic regimen in rats infected with influenza A(H1N1)pdm09 virus.
- Open Access
- 6 January 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (1) , 33
Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury
Myocardial ischemia-reperfusion injury increases myocardial microvascular permeability, leading to enhanced microvascular filtration and interstitial fluid accumulation that is associated with greater microvascular obstruction and inadequate myocardial perfusion. A burst of reactive oxygen species and inflammatory mediators during reperfusion causes myosin light chain kinase (MLCK)-dependent endothelial hyperpermeability, which is considered a preventable cause of reperfusion injury. In the present study, a single intravenous injection of MLCK peptide inhibitor PIK7 (2.5 mg/kg or 40 mg/kg) was found to suppress the vascular hyperpermeability caused by ischemia/reperfusion injury in an in vivo rat model. The antiedemic effect of PIK7 is transient and ceases within 90 min of reperfusion. The early no-reflow detected for the first time after 30 min ischemia in this model of myocardial infarction reduces the area accessible for PIK7. Electron microscopy has shown membrane-bound blebs of endotheliocytes, which partially or completely obturate the capillary lumen, and few capillaries with signs of intercellular gap formation in samples obtained from the center of the early no-reflow zone in control and PIK7-injected rats. Co-injection of PIK7 with NO donor sodium nitroprusside (SNP) increases blood flow in the zone of early no-reflow, while reducing the increased vascular permeability caused by SNP.
- 6 January 2025
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (1) , 33
Open AccessAntiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury
Myocardial ischemia-reperfusion injury increases myocardial microvascular permeability, leading to enhanced microvascular filtration and interstitial fluid accumulation that is associated with greater microvascular obstruction and inadequate myocardial perfusion. A burst of reactive oxygen species and inflammatory mediators during reperfusion causes myosin light chain kinase (MLCK)-dependent endothelial hyperpermeability, which is considered a preventable cause of reperfusion injury. In the present study, a single intravenous injection of MLCK peptide inhibitor PIK7 (2.5 mg/kg or 40 mg/kg) was found to suppress the vascular hyperpermeability caused by ischemia/reperfusion injury in an in vivo rat model. The antiedemic effect of PIK7 is transient and ceases within 90 min of reperfusion. The early no-reflow detected for the first time after 30 min ischemia in this model of myocardial infarction reduces the area accessible for PIK7. Electron microscopy has shown membrane-bound blebs of endotheliocytes, which partially or completely obturate the capillary lumen, and few capillaries with signs of intercellular gap formation in samples obtained from the center of the early no-reflow zone in control and PIK7-injected rats. Co-injection of PIK7 with NO donor sodium nitroprusside (SNP) increases blood flow in the zone of early no-reflow, while reducing the increased vascular permeability caused by SNP.
- Open Access
- 13 December 2024
- Published by MDPI AG in Preprints.org
Antiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury
Myocardial ischemia-reperfusion injury increases myocardial microvascular permea-bility leading to enhanced microvascular filtration and interstitial fluid accumulation that is as-sociated with greater microvascular obstruction and no-reflow formation. A burst of reactive oxygen species and inflammatory mediators during reperfusion causes myosin light chain kinase (MLCK)-dependent endothelial hyperpermeability, which is considered a preventable cause of reperfusion injury. In present study, a single intravenous injection of MLCK peptide inhibitor PIK7 (2.5 mg/kg or 40 mg/kg) was found to suppress vascular hyperpermeability caused by ische-mia/reperfusion injury in in vivo rat model. Antiedemic effect of PIK7 is transient and ceases within 90 minutes of reperfusion. The early no-reflow detected for the first time after 30-min is-chemia in this model of myocardial infarction reduces the area accessible for PIK7. Electron mi-croscopy has shown membrane-bound blebs of endotheliocytes, which partially or completely obturate the capillary lumen, and few capillaries with signs of intercellular gap formation in samples obtained from the center of the early no-reflow zone in control and PIK7 injected rats. Co-injection of PIK7 with NO donor sodium nitroprusside (SNP) increases blood flow in the zone of early no-reflow, while reducing the increased vascular permeability caused by SNP.
- 13 December 2024
- Published by MDPI AG in Preprints.org
Open AccessAntiedemic Effect of the Myosin Light Chain Kinase Inhibitor PIK7 in the Rat Model of Myocardial Ischemia Reperfusion Injury
Myocardial ischemia-reperfusion injury increases myocardial microvascular permea-bility leading to enhanced microvascular filtration and interstitial fluid accumulation that is as-sociated with greater microvascular obstruction and no-reflow formation. A burst of reactive oxygen species and inflammatory mediators during reperfusion causes myosin light chain kinase (MLCK)-dependent endothelial hyperpermeability, which is considered a preventable cause of reperfusion injury. In present study, a single intravenous injection of MLCK peptide inhibitor PIK7 (2.5 mg/kg or 40 mg/kg) was found to suppress vascular hyperpermeability caused by ische-mia/reperfusion injury in in vivo rat model. Antiedemic effect of PIK7 is transient and ceases within 90 minutes of reperfusion. The early no-reflow detected for the first time after 30-min is-chemia in this model of myocardial infarction reduces the area accessible for PIK7. Electron mi-croscopy has shown membrane-bound blebs of endotheliocytes, which partially or completely obturate the capillary lumen, and few capillaries with signs of intercellular gap formation in samples obtained from the center of the early no-reflow zone in control and PIK7 injected rats. Co-injection of PIK7 with NO donor sodium nitroprusside (SNP) increases blood flow in the zone of early no-reflow, while reducing the increased vascular permeability caused by SNP.
- Open Access
- 10 October 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Regional blood circulation and microcirculation
- Vol. 23 (3) , 70-80
Systemic alteration of vasomotor activity of blood vessels in Wistar rats with premorbid chronic cardiomyopathy infected with influenza A(H1N1)pdm09
Системные нарушения вазомоторной активности кровеносных сосудов, вызванные вирусом гриппа A(H1N1)pdm09, на фоне преморбидной хронической кардиомиопатии
- 10 October 2024
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Regional blood circulation and microcirculation
- Vol. 23 (3) , 70-80
Open AccessSystemic alteration of vasomotor activity of blood vessels in Wistar rats with premorbid chronic cardiomyopathy infected with influenza A(H1N1)pdm09
Системные нарушения вазомоторной активности кровеносных сосудов, вызванные вирусом гриппа A(H1N1)pdm09, на фоне преморбидной хронической кардиомиопатии
- Open Access
- 29 December 2023
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Regional blood circulation and microcirculation
- Vol. 22 (4) , 74-86
Duration of systemic alteration in vasomotor function of microvascular endothelium caused by the influenza A(H1N1)pdm09 virus
Introduction. The influenza A virus (IAV) can infect vascular endothelial cells and cause activation and/or dysfunction of the endothelium. Previously, we have shown that the influenza A(H1N1)pdm09 virus leads to alteration in functional activity of blood vessels in different vascular beds, and also causes various histopathological changes in pulmonary blood vessels of Wistar rats in the acute period of infection. Aim – to study the duration of systemic alteration in vasomotor function of microvascular endothelium caused by the influenza A(H1N1)pdm09 virus. Materials and methods. The Wistar rats were intranasally infected with the influenza A/St. Petersburg/48/16 (H1N1)pdm09 virus and at 1, 4, 7, 14, 21, 30, 60 and 90 days post infection (dpi) they were anesthetized and necropsied. The expression level of endothelial nitric oxide synthase (eNOS) was determined in mesenteric vascular endothelium by immunohistochemistry. The vasomotor activity of the mesenteric arteries was studied using wire myography. Results. The influenza A(H1N1)pdm09 virus causes a decrease in eNOS expression by 13–39 % within 60 dpi (p<0.05). In addition, the influenza virus also reduces the maximal response of mesenteric arteries to the vasodilator by 74–108 % within 21 days (p<0.0001) and reduces the response by 16–26 % within 30 and 60 dpi (p<0.0001), respectively, and also increases the maximum response of the arteries to the vasoconstrictor by 26–57 % within 30 dpi (p<0.05). It should be noted that such long-term changes are observed while virus is eliminated by the 7th dpi. Conclusion. The influenza A(H1N1) pdm09 virus causes long-term endothelial dysfunction in the Wistar rats which is characterized by the reduced expression of eNOS in mesenteric microvascular endothelium within 60 dpi, decrease of the maximal response of mesenteric microvessels to vasodilator within 60 dpi and increase of the maximal response to vasoconstrictor within 30 dpi. Alterations of systemic functional activity of mesenteric microvessels in rats infected with influenza A(H1N1)pdm09 virus are registered in absence of the reproduction of virus in mesenteric blood vessels while virus is eliminated from pulmonary tissues by the 7th dpi.
- 29 December 2023
- Published by FSBEI HE I.P. Pavlov SPbSMU MOH Russia in Regional blood circulation and microcirculation
- Vol. 22 (4) , 74-86
Open AccessDuration of systemic alteration in vasomotor function of microvascular endothelium caused by the influenza A(H1N1)pdm09 virus
Introduction. The influenza A virus (IAV) can infect vascular endothelial cells and cause activation and/or dysfunction of the endothelium. Previously, we have shown that the influenza A(H1N1)pdm09 virus leads to alteration in functional activity of blood vessels in different vascular beds, and also causes various histopathological changes in pulmonary blood vessels of Wistar rats in the acute period of infection. Aim – to study the duration of systemic alteration in vasomotor function of microvascular endothelium caused by the influenza A(H1N1)pdm09 virus. Materials and methods. The Wistar rats were intranasally infected with the influenza A/St. Petersburg/48/16 (H1N1)pdm09 virus and at 1, 4, 7, 14, 21, 30, 60 and 90 days post infection (dpi) they were anesthetized and necropsied. The expression level of endothelial nitric oxide synthase (eNOS) was determined in mesenteric vascular endothelium by immunohistochemistry. The vasomotor activity of the mesenteric arteries was studied using wire myography. Results. The influenza A(H1N1)pdm09 virus causes a decrease in eNOS expression by 13–39 % within 60 dpi (p<0.05). In addition, the influenza virus also reduces the maximal response of mesenteric arteries to the vasodilator by 74–108 % within 21 days (p<0.0001) and reduces the response by 16–26 % within 30 and 60 dpi (p<0.0001), respectively, and also increases the maximum response of the arteries to the vasoconstrictor by 26–57 % within 30 dpi (p<0.05). It should be noted that such long-term changes are observed while virus is eliminated by the 7th dpi. Conclusion. The influenza A(H1N1) pdm09 virus causes long-term endothelial dysfunction in the Wistar rats which is characterized by the reduced expression of eNOS in mesenteric microvascular endothelium within 60 dpi, decrease of the maximal response of mesenteric microvessels to vasodilator within 60 dpi and increase of the maximal response to vasoconstrictor within 30 dpi. Alterations of systemic functional activity of mesenteric microvessels in rats infected with influenza A(H1N1)pdm09 virus are registered in absence of the reproduction of virus in mesenteric blood vessels while virus is eliminated from pulmonary tissues by the 7th dpi.
- Open Access
Influenza A(H1N1)pdm09 Virus Aggravates Pathology of Blood Vessels in Wistar Rats with Premorbid Acute Cardiomyopathy
Influenza virus can infect the vascular endothelium and cause endothelial dysfunction. Persons at higher risk for severe influenza are patients with acute and chronic cardiovascular disorders; however, the mechanism of influenza-induced cardiovascular system alteration remains not fully understood. The aim of the study was to assess the functional activity of mesenteric blood vessels of Wistar rats with premorbid acute cardiomyopathy infected with Influenza A(H1N1)pdm09 virus. For this, we determined (1) the vasomotor activity of mesenteric blood vessels of Wistar rats using wire myography, (2) the level of expression of three endothelial factors: endothelial nitric oxide synthase (eNOS), plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator (tPA) in the endothelium of mesenteric blood vessels using immunohistochemistry, and (3) the concentration of PAI-1 and tPA in the blood plasma using ELISA. Acute cardiomyopathy in animals was induced by doxorubicin (DOX) following infection with rat-adapted Influenza A(H1N1)pdm09 virus. The functional activity of mesenteric blood vessels was analyzed at 24 and 96 h post infection (hpi). Thus, the maximal response of mesenteric arteries to both vasoconstrictor and vasodilator at 24 and 96 hpi was significantly decreased compared with control. Expression of eNOS in the mesenteric vascular endothelium was modulated at 24 and 96 hpi. PAI-1 expression increased 3.47-fold at 96 hpi, while the concentration of PAI-1 in the blood plasma increased 6.43-fold at 24 hpi compared with control. The tPA concentration in plasma was also modulated at 24 hpi and 96 hpi. The obtained data indicate that influenza A(H1N1)pdm09 virus aggravates the course of premorbid acute cardiomyopathy in Wistar rats, causing pronounced dysregulation of endothelial factor expression and vasomotor activity impairment of mesenteric arteries.
Open AccessInfluenza A(H1N1)pdm09 Virus Aggravates Pathology of Blood Vessels in Wistar Rats with Premorbid Acute Cardiomyopathy
Influenza virus can infect the vascular endothelium and cause endothelial dysfunction. Persons at higher risk for severe influenza are patients with acute and chronic cardiovascular disorders; however, the mechanism of influenza-induced cardiovascular system alteration remains not fully understood. The aim of the study was to assess the functional activity of mesenteric blood vessels of Wistar rats with premorbid acute cardiomyopathy infected with Influenza A(H1N1)pdm09 virus. For this, we determined (1) the vasomotor activity of mesenteric blood vessels of Wistar rats using wire myography, (2) the level of expression of three endothelial factors: endothelial nitric oxide synthase (eNOS), plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator (tPA) in the endothelium of mesenteric blood vessels using immunohistochemistry, and (3) the concentration of PAI-1 and tPA in the blood plasma using ELISA. Acute cardiomyopathy in animals was induced by doxorubicin (DOX) following infection with rat-adapted Influenza A(H1N1)pdm09 virus. The functional activity of mesenteric blood vessels was analyzed at 24 and 96 h post infection (hpi). Thus, the maximal response of mesenteric arteries to both vasoconstrictor and vasodilator at 24 and 96 hpi was significantly decreased compared with control. Expression of eNOS in the mesenteric vascular endothelium was modulated at 24 and 96 hpi. PAI-1 expression increased 3.47-fold at 96 hpi, while the concentration of PAI-1 in the blood plasma increased 6.43-fold at 24 hpi compared with control. The tPA concentration in plasma was also modulated at 24 hpi and 96 hpi. The obtained data indicate that influenza A(H1N1)pdm09 virus aggravates the course of premorbid acute cardiomyopathy in Wistar rats, causing pronounced dysregulation of endothelial factor expression and vasomotor activity impairment of mesenteric arteries.
- Open Access
Influenza A(H1N1)pdm09 Virus Alters Expression of Endothelial Factors in Pulmonary Vascular Endothelium in Rats
Influenza virus infection may cause endothelial activation and dysfunction. However, it is still not known to what extent the influenza virus can dysregulate the expression of various endothelial proteins. The aim of the study is to identify the level of expression of endothelial nitric oxide synthase (eNOS), plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator (tPA) in the pulmonary vascular endothelium, as well as the concentration of PAI-1 and tPA in the blood plasma in Wistar rats. Animals were intranasally infected with rat-adapted influenza A(H1N1)pdm09 virus. The expression of eNOS, PAI-1 and tPA in the pulmonary vascular endothelium was determined by immunohistochemistry; the concentration of PAI-1 and tPA was analyzed by ELISA at 24 and 96 h post infection (hpi). Thus, the expression of eNOS in the pulmonary vascular endothelium decreased by 1.9-fold at 24 hpi and increased by 2-fold at 96 hpi. The expression of PAI-1 in the pulmonary vascular endothelium increased by 5.23-fold and 6.54-fold at 24 and 96 hpi, respectively. The concentration of PAI-1 in the blood plasma of the rats decreased by 3.84-fold at 96 hpi, but not at 24 hpi. The expression of tPA in the pulmonary vascular endothelium was increased 2.2-fold at 96 hpi. The obtained data indicate the development of endothelial dysfunction that is characterized by the dysregulation of endothelial protein expression in non-lethal and clinically non-severe experimental influenza virus infection.
Open AccessInfluenza A(H1N1)pdm09 Virus Alters Expression of Endothelial Factors in Pulmonary Vascular Endothelium in Rats
Influenza virus infection may cause endothelial activation and dysfunction. However, it is still not known to what extent the influenza virus can dysregulate the expression of various endothelial proteins. The aim of the study is to identify the level of expression of endothelial nitric oxide synthase (eNOS), plasminogen activator inhibitor-1 (PAI-1), and tissue plasminogen activator (tPA) in the pulmonary vascular endothelium, as well as the concentration of PAI-1 and tPA in the blood plasma in Wistar rats. Animals were intranasally infected with rat-adapted influenza A(H1N1)pdm09 virus. The expression of eNOS, PAI-1 and tPA in the pulmonary vascular endothelium was determined by immunohistochemistry; the concentration of PAI-1 and tPA was analyzed by ELISA at 24 and 96 h post infection (hpi). Thus, the expression of eNOS in the pulmonary vascular endothelium decreased by 1.9-fold at 24 hpi and increased by 2-fold at 96 hpi. The expression of PAI-1 in the pulmonary vascular endothelium increased by 5.23-fold and 6.54-fold at 24 and 96 hpi, respectively. The concentration of PAI-1 in the blood plasma of the rats decreased by 3.84-fold at 96 hpi, but not at 24 hpi. The expression of tPA in the pulmonary vascular endothelium was increased 2.2-fold at 96 hpi. The obtained data indicate the development of endothelial dysfunction that is characterized by the dysregulation of endothelial protein expression in non-lethal and clinically non-severe experimental influenza virus infection.